FDA Inspection 1168908 — Sandeep Jasuja
The FDA completed an inspection of Sandeep Jasuja on Apr 1, 2022 in Jaipur. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Jaipur (India)
Additional Details
Clinical Investigator (CI)